PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement.

Chemsex Human immunodeficiency virus Infecciones de transmisión sexual Pre-exposure prophylaxis Profilaxis preexposición Sexually transmitted infections Virus de la inmunodeficiencia humana

Journal

Enfermedades infecciosas y microbiologia clinica (English ed.)
ISSN: 2529-993X
Titre abrégé: Enferm Infecc Microbiol Clin (Engl Ed)
Pays: Spain
ID NLM: 101777541

Informations de publication

Date de publication:
01 2023
Historique:
received: 13 02 2021
revised: 03 04 2021
accepted: 07 04 2021
pubmed: 10 7 2022
medline: 11 1 2023
entrez: 9 7 2022
Statut: ppublish

Résumé

Pre-Exposure Prophylaxis (PrEP) is a biomedical intervention to prevent HIV infection in seronegative people at high risk of becoming infected. This strategy was endorsed in October 2019 by the Spanish Ministry of Health. To present the PrEP initial experience in the HIV Unit of the Hospital Clínic of Barcelona, paying special attention to the analysis of the vulnerability factors in the cohort. Retrospective, descriptive study. The epidemiological, sociodemographic, and clinical characteristics of the users included in the program during the first year are analyzed, paying particular attention to Infections, risky practices, and substance use. 190 individuals were included, 177 men and 12 trans women with a mean age of 35 years (8 SD). 70% had higher education, and half had Spanish nationality. An average of 10 couples per trimester and 60% reported unprotected anal sex. 31% had at least one positive PCR for STIs, with N. gonorrhoeae being the most prevalent microorganism (51%) and the rectal sample the most affected (21%). 63% reported chemsex use, 19% polydrug use, and 8% "slamming". Half expressed concern about consumption and/or sexual practices and 25% the need for help. The PrEP user profile attended in our Hospital Unit justifies the creation of multidisciplinary teams that allow us to provide holistic attention to the sexual life of these people.

Identifiants

pubmed: 35810144
pii: S2529-993X(22)00139-3
doi: 10.1016/j.eimce.2022.06.009
pii:
doi:

Types de publication

Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

24-28

Commentaires et corrections

Type : CommentOn

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

Montserrat Laguno (M)

Unidad de VIH, Hospital Clínic e IDIBAPS, Universidad de Barcelona, Barcelona, Spain. Electronic address: mlaguno@clinic.cat.

Ainoa Ugarte (A)

Unidad de VIH, Hospital Clínic e IDIBAPS, Universidad de Barcelona, Barcelona, Spain.

María Martinez-Rebollar (M)

Unidad de VIH, Hospital Clínic e IDIBAPS, Universidad de Barcelona, Barcelona, Spain.

Yeray Sobrino (Y)

Unidad de VIH, Hospital Clínic e IDIBAPS, Universidad de Barcelona, Barcelona, Spain.

Guillermo Font (G)

Unidad de VIH, Hospital Clínic e IDIBAPS, Universidad de Barcelona, Barcelona, Spain.

Elisa de Lazzari (E)

Unidad de VIH, Hospital Clínic e IDIBAPS, Universidad de Barcelona, Barcelona, Spain.

Lorena de la Mora (L)

Unidad de VIH, Hospital Clínic e IDIBAPS, Universidad de Barcelona, Barcelona, Spain.

Berta Torres (B)

Unidad de VIH, Hospital Clínic e IDIBAPS, Universidad de Barcelona, Barcelona, Spain.

Iván Chivite (I)

Unidad de VIH, Hospital Clínic e IDIBAPS, Universidad de Barcelona, Barcelona, Spain.

Josep Riera (J)

Servicio de Dermatología, Hospital Clínic e IDIBAPS, Universidad de Barcelona, Barcelona, Spain.

Juan Ambrosioni (J)

Unidad de VIH, Hospital Clínic e IDIBAPS, Universidad de Barcelona, Barcelona, Spain.

Alexy Inciarte (A)

Unidad de VIH, Hospital Clínic e IDIBAPS, Universidad de Barcelona, Barcelona, Spain.

Ana Gonzalez-Cordon (A)

Unidad de VIH, Hospital Clínic e IDIBAPS, Universidad de Barcelona, Barcelona, Spain.

Jhon Rojas (J)

Unidad de VIH, Hospital Clínic e IDIBAPS, Universidad de Barcelona, Barcelona, Spain.

Encarna Cordon (E)

Unidad de VIH, Hospital Clínic e IDIBAPS, Universidad de Barcelona, Barcelona, Spain.

José Luis Blanco (JL)

Unidad de VIH, Hospital Clínic e IDIBAPS, Universidad de Barcelona, Barcelona, Spain.

Esteban Martinez (E)

Unidad de VIH, Hospital Clínic e IDIBAPS, Universidad de Barcelona, Barcelona, Spain.

Josep Mallolas (J)

Unidad de VIH, Hospital Clínic e IDIBAPS, Universidad de Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH